Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages
Open Access
- 15 October 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 165 (8) , 4272-4280
- https://doi.org/10.4049/jimmunol.165.8.4272
Abstract
Gram-negative bacteria and the LPS constituent of their outer membranes stimulate the release of inflammatory mediators believed to be responsible for the clinical manifestations of septic shock. The GPI-linked membrane protein, CD14, initiates the signaling cascade responsible for the induction of this inflammatory response by LPS. In this paper, we report the generation and characterization of CD14-null mice in which the entire coding region of CD14 was deleted. As expected, LPS failed to elicit TNF-α and IL-6 production in macrophages taken from these animals, and this loss in responsiveness is associated with impaired activation of both the NF-κB and the c-Jun N-terminal mitogen-activated protein kinase pathways. The binding and uptake of heat-killed Escherichia coli, measured by FACS analysis, did not differ between CD14-null and wild-type macrophages. However, in contrast to the findings with LPS, whole E. coli stimulated similar levels of TNF-α release from CD14-null and wild-type macrophages at a dose of 10 bioparticles per cell. This effect was dose dependent, and at lower bacterial concentrations CD14-deficient macrophages produced significantly less TNF-α than wild type. Approximately half of this CD14-independent response appeared to be mediated by CD11b/CD18, as demonstrated by receptor blockade using neutrophil inhibitory factor. An inhibitor of phagocytosis, cytochalasin B, abrogated the induction of TNF-α in CD14-deficient macrophages by E. coli. These data indicate that CD14 is essential for macrophage responses to free LPS, whereas other receptors, including CD11b/CD18, can compensate for the loss of CD14 in response to whole bacteria.Keywords
This publication has 47 references indexed in Scilit:
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- Ectodomain interactions of leukocyte integrins and pro-inflammatory GPI-linked membrane proteinsJournal of Pharmaceutical and Biomedical Analysis, 1997
- Solvent-accessible Residues on the Metal Ion-dependent Adhesion Site Face of Integrin CR3 Mediate Its Binding to the Neutrophil Inhibitory FactorPublished by Elsevier ,1996
- Integrins as promiscuous signal transduction devicesImmunology Today, 1996
- Resistance to Endotoxin Shock and Reduced Dissemination of Gram-Negative Bacteria in CD14-Deficient MiceImmunity, 1996
- Both membrane‐bound and soluble forms of CD14 bind to Gram‐negative bacteriaEuropean Journal of Immunology, 1995
- Particle GoddessScientific American, 1992
- BIOCHEMISTRY OF ENDOTOXINSAnnual Review of Biochemistry, 1990
- CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide.The Journal of Experimental Medicine, 1989
- Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.The Journal of Experimental Medicine, 1982